首页> 外文期刊>Circulation journal >Comparison of the axillary venous approach and subclavian venous approach for effcacy of permanent pacemaker implantation - 8-year follow-up results
【24h】

Comparison of the axillary venous approach and subclavian venous approach for effcacy of permanent pacemaker implantation - 8-year follow-up results

机译:腋窝静脉入路和锁骨下静脉入路对永久性起搏器植入的疗效比较-8年随访结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Long-term data on lead complication rates are limited for both the axillary and subclavian venous approaches for permanent pacemaker implantation. Methods and Results: We conducted a single-center, retrospective, nonrandomized comparison. We reviewed the patients who had consented to receiving a permanent pacemaker implant. A superficial landmark or radiographic contrast guiding was used for the axillary venous approach, whereas conventional landmarks were used for the subclavian venous approach. From January 1992 to December 2005, we analyzed 1,161 permanent pacemaker leads in 655 patients [subclavian venous approach (group I: 338 patients, 542 leads) and axillary venous approach (group II: 317 patients, 619 leads)]. Baseline characteristics of the patients did not differ. However, DDD-pacemakers and atrial leads were used more often in group II than in group I (94% vs. 62% and 49% vs. 40%, P<0.01). During the 8-year follow-up, lead complication rates were lower in group II (17 leads, 3%) than in group I (31 leads, 6%) (P=0.03), and group II had a better complication-free survival curve than group I with a 49% relative risk reduction in lead complication rates (hazard ratio =0.51; 95% confidence interval, 0.27-0.94; P=0.03). Conclusions: The axillary venous approach for permanent pacemaker implantation has better long-term efficacy and lower lead complication rates than the subclavian venous approach.
机译:背景:永久性起搏器植入的腋窝和锁骨下静脉入路的铅并发症发生率的长期数据有限。方法和结果:我们进行了单中心,回顾性,非随机比较。我们审查了同意接受永久性起搏器植入物的患者。腋窝静脉入路采用表面标志或放射线对比指导,锁骨下静脉入路采用常规标志。从1992年1月至2005年12月,我们分析了655例患者的1,161根永久性起搏器导线[锁骨下静脉入路(第一组:338例患者,542根导线)和腋静脉入路(第二组:317例患者,619根导线)]。患者的基线特征没有差异。然而,与第一组相比,第二组中使用DDD起搏器和心房导线的频率更高(94%比62%和49%比40%,P <0.01)。在8年的随访期间,第二组的铅并发症发生率(17根铅,3%)低于第一组(31铅,6%)(P = 0.03),第二组的无并发症更好生存曲线比第一组的铅并发症发生率降低了49%(危险比= 0.51; 95%置信区间为0.27-0.94; P = 0.03)。结论:与锁骨下静脉手术相比,永久性起搏器植入的腋静脉手术具有更好的长期疗效和更低的导线并发症发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号